Skip to main content

Equibles does not estimate personal net worth.

Get an email with a short summary when Design Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.

Get DSGN alerts

About Deepa Prasad

Design Therapeutics, Inc. reported in an 8-K filed January 30, 2026 that Deepa Prasad resigned as Board of Directors, effective February 1, 2026. Design Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Design Therapeutics, Inc. includes Pratik Shah (CEO and Board Member), Pratik Shah, Ph.D. (CEO), Sean Jeffries (COO) and 7 others.

“On January 29, 2026, Deepa Prasad notified Design Therapeutics, Inc. (the "Company") of her decision to resign from the Company's Board of Directors, effective February 1, 2026, due to required conflict-avoidance policies associated with her newly appointed role with a major bank.”
Design Therapeutics, Inc. Form 8-K, filed January 30, 2026 · Read the filing

Affiliation history

Company network

Leadership on record at Design Therapeutics, Inc.

Recent activity